Rejuvenate Bio reposted this
Rejuvenate Bio lands $4m grant to develop gene therapy with longevity potential California Institute for Regenerative Medicine (CIRM) funding will support the company through IND-enabling studies of FGF21-boosting gene therapy for genetic heart condition. #longevity #funding #genetherapy
Our CEO Daniel Oliver spoke on a panel on Commercialization Strategies for Biotechs and Early Planning at the LSX USA Congress in Boston. Great meeting everyone and see you all at the next event!
BioProcess International speaks with our CEO & Co-Founder Daniel Oliver about our $4M CIRM grant and what’s next for the company. 🧬🧬 Gene-therapy developer Rejuvenate Bio was recently awarded $4 million by the California Institute for Regenerative Medicine (CIRM) to pursue investigational new drug (IND) activities for RJB-0402 to treat desmoplakin gene variant arrhythmogenic cardiomyopathy (DSP ACM). Rejuvenate Bio will use the funds to perform confirmatory animal studies in mice and non-human primates; support manufacturing scale-up through helping attain representative good manufacturing practice (GMP) materials; and perform patient outreach. Read the article: https://lnkd.in/exviT_pe
